Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.
2.

Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials.

Kovanda LL, Walsh TJ, Benjamin DK Jr, Arrieta A, Kaufman DA, Smith PB, Manzoni P, Desai AV, Kaibara A, Bonate PL, Hope WW.

Pediatr Infect Dis J. 2018 Jun;37(6):580-585. doi: 10.1097/INF.0000000000001957.

3.

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.

Benjamin DK Jr, Kaufman DA, Hope WW, Smith PB, Arrieta A, Manzoni P, Kovanda LL, Lademacher C, Isaacson B, Jednachowski D, Wu C, Kaibara A, Walsh TJ.

Pediatr Infect Dis J. 2018 Oct;37(10):992-998. doi: 10.1097/INF.0000000000001996. Erratum in: Pediatr Infect Dis J. 2018 Nov;37(11):1198.

4.

Pharmacokinetic drug interaction study between overactive bladder drugs mirabegron and tolterodine in Japanese healthy postmenopausal females.

Nomura Y, Iitsuka H, Toyoshima J, Kuroishi K, Hatta T, Kaibara A, Katashima M, Moy S, Sawamoto T.

Drug Metab Pharmacokinet. 2016 Dec;31(6):411-416. doi: 10.1016/j.dmpk.2016.08.002. Epub 2016 Aug 18.

PMID:
27829538
5.

Integrative pharmacokinetic-pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes.

Takada A, Katashima M, Kaibara A, Chono K, Katsumata K, Sawamoto T, Suzuki H, Yano Y.

Drug Metab Pharmacokinet. 2016 Aug;31(4):323-32. doi: 10.1016/j.dmpk.2016.05.005. Epub 2016 Jun 10.

PMID:
27461507
6.

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients.

Zhu T, Keirns J, Howieson C, Kaibara A, Goldwater R, Kivitz AJ, Chindalore V, Cohen S, Santos V, Akinlade B, Kernstock R, Delgado-Herrera L, Blahunka PC, Karrer EE, Garg JP, Samberg N, Zeiher BG.

Clin Pharmacol Drug Dev. 2016 Sep;5(5):408-25. doi: 10.1002/cpdd.251. Epub 2016 Mar 28.

PMID:
27410490
7.

Comparison of the safety, tolerability, and pharmacokinetics of fidaxomicin in healthy Japanese and caucasian subjects.

Oshima H, Yamazaki T, Benner L, Miki T, Michon I, Wojtkowski T, Kaibara A, Mujais S.

Clin Drug Investig. 2015 Jun;35(6):375-84. doi: 10.1007/s40261-015-0291-9.

8.

Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents.

Hope WW, Kaibara A, Roy M, Arrieta A, Azie N, Kovanda LL, Benjamin DK Jr.

Antimicrob Agents Chemother. 2015 Feb;59(2):905-13. doi: 10.1128/AAC.03736-14. Epub 2014 Nov 24.

9.

Clinicopathological evaluation of anoxic mucosal injury in strangulation ileus.

Takahashi R, Akagi Y, Tanaka T, Kaibara A, Kajiwara S, Shima I, Taguchi J, Mizobe T, Kakuma T, Shirouzu K.

BMC Surg. 2014 Oct 16;14:79. doi: 10.1186/1471-2482-14-79.

10.

Statistical analysis of Amenamevir (ASP2151) between pharmacokinetics and clinical efficacies with non-linear effect model for the treatment of genital herpes.

Takada A, Katashima M, Kaibara A, Sawamoto T, Zhang W, Keirns J.

Clin Pharmacol Drug Dev. 2014 Sep;3(5):365-70. doi: 10.1002/cpdd.108. Epub 2014 Feb 17.

PMID:
27129009
11.

Effect of preoperative administration of methylpredonisolone and ulinastatin on tumor cell metastasis after surgical stress.

Momosaki K, Ishibashi N, Yoshida S, Muraoka T, Tanaka K, Iwakuma N, Oka Y, Kaibara A, Akagi Y, Shirouzu K.

Kurume Med J. 2014;60(3-4):79-88. Epub 2014 Feb 17.

12.

Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer.

Ogata Y, Tanaka T, Akagi Y, Ishibashi N, Tsuji Y, Matono K, Isobe M, Sueyoshi S, Kaibara A, Shirouzu K.

Clin Med Insights Oncol. 2013;7:21-30. doi: 10.4137/CMO.S10769. Epub 2013 Feb 10.

13.

A phase 1, randomized ascending single-dose study of antagonist anti-human CD40 ASKP1240 in healthy subjects.

Goldwater R, Keirns J, Blahunka P, First R, Sawamoto T, Zhang W, Kowalski D, Kaibara A, Holman J.

Am J Transplant. 2013 Apr;13(4):1040-1046. doi: 10.1111/ajt.12082. Epub 2013 Jan 28.

14.

Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study.

Malik M, van Gelderen EM, Lee JH, Kowalski DL, Yen M, Goldwater R, Mujais SK, Schaddelee MP, de Koning P, Kaibara A, Moy SS, Keirns JJ.

Clin Pharmacol Ther. 2012 Dec;92(6):696-706. doi: 10.1038/clpt.2012.181. Epub 2012 Nov 14.

PMID:
23149929
15.
16.

Guidelines for the quality control of population pharmacokinetic-pharmacodynamic analyses: an industry perspective.

Bonate PL, Strougo A, Desai A, Roy M, Yassen A, van der Walt JS, Kaibara A, Tannenbaum S.

AAPS J. 2012 Dec;14(4):749-58. doi: 10.1208/s12248-012-9387-9. Epub 2012 Jul 24. Review.

17.

Population pharmacokinetics of micafungin in neonates and young infants.

Hope WW, Smith PB, Arrieta A, Buell DN, Roy M, Kaibara A, Walsh TJ, Cohen-Wolkowiez M, Benjamin DK Jr.

Antimicrob Agents Chemother. 2010 Jun;54(6):2633-7. doi: 10.1128/AAC.01679-09. Epub 2010 Mar 22.

18.

Population pharmacokinetic analysis of micafungin in Japanese patients with fungal infections.

Tabata K, Katashima M, Kawamura A, Kaibara A, Tanigawara Y.

Drug Metab Pharmacokinet. 2006 Aug;21(4):324-31.

19.

A case report of disseminated recurrence of inferior bile duct carcinoma in PTCD fistula.

Matsumoto A, Imamura M, Akagi Y, Kaibara A, Ohkita A, Mizobe T, Isomoto H, Aoyagi S.

Kurume Med J. 2002;49(1-2):71-5.

20.

Glutamine supplementation in cancer patients.

Yoshida S, Kaibara A, Ishibashi N, Shirouzu K.

Nutrition. 2001 Sep;17(9):766-8.

PMID:
11527675
21.

Endoscopic decompression procedure in acute obstructing colorectal cancer.

Araki Y, Isomoto H, Matsumoto A, Kaibara A, Yasunaga M, Hayashi K, Yatsugi H, Yamauchi K.

Endoscopy. 2000 Aug;32(8):641-3.

PMID:
10935794
22.

An in vitro chemosensitivity test for colorectal cancer using collagen-gel droplet embedded cultures.

Araki Y, Isomoto H, Matsumoto A, Kaibara A, Yasunaga M, Hayashi K, Yatsugi H, Yamauchi K.

Kurume Med J. 1999;46(3-4):163-6.

23.

Effect of surgical stress on endogenous morphine and cytokine levels in the plasma after laparoscopoic or open cholecystectomy.

Yoshida S, Ohta J, Yamasaki K, Kamei H, Harada Y, Yahara T, Kaibara A, Ozaki K, Tajiri T, Shirouzu K.

Surg Endosc. 2000 Feb;14(2):137-40.

PMID:
10656946
24.

Leptin produces anorexia and weight loss without inducing an acute phase response or protein wasting.

Kaibara A, Moshyedi A, Auffenberg T, Abouhamze A, Copeland EM 3rd, Kalra S, Moldawer LL.

Am J Physiol. 1998 Jun;274(6):R1518-25. doi: 10.1152/ajpregu.1998.274.6.R1518.

PMID:
9608004
25.

Interleukin 6, but not ciliary neurotrophic factor or leukaemia inhibitory factor, is responsible for the acute phase response to turpentine-induced myositis.

Kaibara A, Espat NJ, Auffenberg T, Abouhamze AS, Martin D, Kalra S, Moldawer LL.

Cytokine. 1998 Jun;10(6):452-6.

PMID:
9632532
26.

Pharmacokinetics, immunogenicity, and efficacy of dimeric TNFR binding proteins in healthy and bacteremic baboon.

Solorzano CC, Kaibara A, Hess PJ, Edwards PD, Ksontini R, Abouhamze A, McDaniel S, Frazier J, Trujillo D, Kieft G, Seely J, Kohno T, Cosenza ME, Clare-Salzler M, MacKay SL, Martin SW, Moldawer LL, Edwards CK 3rd.

J Appl Physiol (1985). 1998 Apr;84(4):1119-30.

27.

Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.

Xu B, Dube MG, Kalra PS, Farmerie WG, Kaibara A, Moldawer LL, Martin D, Kalra SP.

Endocrinology. 1998 Feb;139(2):466-73.

PMID:
9449612
28.

Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor.

Solorzano CC, Ksontini R, Pruitt JH, Hess PJ, Edwards PD, Kaibara A, Abouhamze A, Auffenberg T, Galardy RE, Vauthey JN, Copeland EM 3rd, Edwards CK 3rd, Lauwers GY, Clare-Salzler M, MacKay SL, Moldawer LL, Lazarus DD.

J Immunol. 1997 Jan 1;158(1):414-9.

PMID:
8977217
29.

A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon.

Welborn MB 3rd, Van Zee K, Edwards PD, Pruitt JH, Kaibara A, Vauthey JN, Rogy M, Castleman WL, Lowry SF, Kenney JS, Stüber D, Ettlin U, Wipf B, Loetscher H, Copeland EM 3rd, Lesslauer W, Moldawer LL.

J Exp Med. 1996 Jul 1;184(1):165-71.

30.

Effect of fentanyl citrate analgesia on glucose production following trauma in rats.

Yoshida S, Hashimoto M, Yamasaki K, Kaibara A, Shirouzu Y, Kakegawa T, Shirouzu K.

J Surg Res. 1996 Mar;61(2):537-42.

PMID:
8656639
31.

Effect of glutamine supplementation on protein metabolism and glutathione in tumor-bearing rats.

Yoshida S, Kaibara A, Yamasaki K, Ishibashi N, Noake T, Kakegawa T.

JPEN J Parenter Enteral Nutr. 1995 Nov-Dec;19(6):492-7.

PMID:
8748364
32.

Effect of methionine-deprived total parenteral nutrition on tumor protein turnover in rats.

Yoshida S, Yamasaki K, Kaibara A, Takagi K, Noake T, Ishibashi N, Kakegawa T.

Cancer. 1995 Oct 1;76(7):1275-82.

PMID:
8630909
33.

Effect of glutamine and chemotherapy on protein metabolism in tumor-bearing rats.

Kaibara A, Yoshida S, Yamasaki K, Ishibashi N, Kakegawa T.

J Surg Res. 1994 Jul;57(1):143-9.

PMID:
8041129
34.

[Glutamine (Gln) supplementation in septic rats].

Yoshida S, Yamasaki K, Kaibara A, Mizote H, Kakegawa T.

Nihon Geka Gakkai Zasshi. 1993 Oct;94(10):1078-84. Japanese.

PMID:
8232182
35.

Oral absorption of FK506 in rats.

Kagayama A, Tanimoto S, Fujisaki J, Kaibara A, Ohara K, Iwasaki K, Hirano Y, Hata T.

Pharm Res. 1993 Oct;10(10):1446-50.

PMID:
7505939
36.

Supplemental Content

Loading ...
Support Center